Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...
Background: Gastroesophageal reflux occurs mainly during the daytime in patients with Los Angeles grade A esophagitis, but predominantly during the night in patients with grade C and D esophagitis.
Eosinophilic Esophagitis Histology Scoring System scores, which evaluate the severity and extent of EoE, showed the largest percent reduction of any cohort to date at 12 weeks, with peak reduction of ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a significant milestone for the Company’s TissueCypher Barrett’s ...
Certain vitamin deficiencies may signal an increased risk of cancer. Low levels of vitamins C, A, and D, as well as the trace ...
The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in ...
A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the ...
Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, ...
After a catastrophic train derailment changed residents' lives forever, politicians used East Palestine, OH, to help ...
When she was in the 11th grade at Wellington High School ... She needed the procedure because her failing liver was causing ...
Q3 Revenue of $12.3 million; a $3.2M and 35% increase year-over-year ●Q3 Test volume up 26% year over year to record levels ●Q3 Cash ...
My name is Julianne, and I will be your conference facilitator today for Amgen's third quarter 2024 financial results ...